Journal Mobile Options
Table of Contents
Vol. 78, No. 3, 2007
Issue release date: April 2007
Urol Int 2007;78:235–240

Adult Male Circumcision Outcomes: Experience in a Developing Country Setting

Krieger J.N. · Bailey R.C. · Opeya J.C. · Ayieko B.O. · Opiyo F.A. · Omondi D. · Agot K. · Parker C. · Ndinya-Achola J.O. · Moses S.
aDepartment of Urology, University of Washington, Seattle, Wash., bDivision of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, Ill., and cRTI International, Research Triangle Park, N.C., USA; dUNIM Project, Kisumu, and eDepartment of Medical Microbiology, University of Nairobi, Nairobi, Kenya; fDepartment of Medical Microbiology, Community Health Sciences and Medicine, University of Manitoba, Winnipeg, Canada

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Introduction: We examined male circumcision outcomes among young adults in an African setting. Materials and Methods: Participants were healthy, sexually active, uncircumcised, HIV-seronegative males aged 18–24 years. The main outcomes measured included complications, healing, satisfaction and resumption of activities. Results: Of 1,475 procedures, 26 (1.8%) were associated with 27 adverse events, most commonly wound disruption/delayed healing (0.6%), wound infection (0.4%), and bleeding (0.3%). Adverse events per clinician averaged 3.8 and 2.1% for procedures 1–100 and 101–200, respectively, and <1% for procedures 201–300, 301–400 and >400, respectively (p < 0.001). Participants resumed normal general activities after a median of 1 postoperative day and 93% with regular employment resumed working within 1 week. After 30 days, 99% of participants reported being very satisfied. After 90 days, 65% reported having had sex, 45% reported that their partners had expressed an opinion, 92% of whom were very satisfied with the outcome. Conclusions: Safe and acceptable adult male circumcision services can be delivered in developing country settings.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Bailey RC, Muga R, Poulussen R, Abicht H: The acceptability of male circumcision to reduce HIV infections in Nyanza Province, Kenya. AIDS Care 2002;14:27–40.
  2. Weiss HA, Quigley MA, Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. Aids 2000;14:2361–2370.
  3. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005;2:e298.
  4. Caldwell JC, Caldwell P: The African AIDS epidemic. Sci Am 1996;274:62–63, 66–68.
  5. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S: Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105–1112.
  6. Lagarde E, Dirk T, Puren A, Reathe RT, Bertran A: Acceptability of male circumcision as a tool for preventing HIV infection in a highly infected community in South Africa. Aids 2003;17:89–95.
  7. Kebaabetswe P, Lockman S, Mogwe S, Mandevu R, Thior I, Essex M, Shapiro RL: Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect 2003;79:214–219.
  8. Mayatula V, Mavundla TR: A review on male circumcision procedures among South African blacks. Curationis 1997;20:16–20.
  9. Ahmed A, Mbibi NH, Dawam D, Kalayi GD: Complications of traditional male circumcision. Ann Trop Paediatr 1999;19:113–117.
  10. Crowley IP, Kesner KM: Ritual circumcision (Umkhwetha) amongst the Xhosa of the Ciskei. Br J Urol 1990;66:318–321.
  11. Magoha GA: Circumcision in various Nigerian and Kenyan hospitals. East Afr Med J 1999;76:583–586.
  12. Khalifa S: Implications of the Protective Effect of Male Circumcision against HIV: A Review of Male Circumcision Procedures Currently Used in Africa and Their Safety. London, London School of Hygiene and Tropical Medicine, 2000.
  13. Manji KP: Circumcision of the young infant in a developing country using the Plastibell. Ann Trop Paediatr 2000;20:101–104.
  14. Williams N, Kapila L: Complications of circumcision. Br J Surg 1993;80:1231–1236.
  15. Wiswell TE, Geschke DW: Risks from circumcision during the first month of life compared with those for uncircumcised boys. Pediatrics 1989;83:1011–1015.
  16. Ben Chaim J, Livne PM, Binyamini J, Hardak B, Ben-Meir D, Mor Y: Complications of circumcision in Israel: a one year multicenter survey. Isr Med Assoc J 2005;7:368–370.
  17. USAID/AIDSMark: Male Circumcision: Current Epidemiological and Field Experience; Program and Policy Implications for HIV Prevention and Reproductive Health. Conference Report. Washington, USAID, 2003.
  18. Mattson CL, Muga R, Poulussen R, Onyango T, Bailey RC: Feasibility of medical male circumcision in Nyanza Province, Kenya. East Afr Med J 2004;81:230–235.
  19. Bailey RC, Muga R, Poulussen R, Abicht H: The acceptability of male circumcision to reduce HIV infection in Nyanza Province, Kenya. AIDS Care 2002;14:27–40.
  20. Krieger JN, Bailey RC, Opeya J, Ayieko B, Opiyo F, Agot K, Parker C, Ndinya-Achola JO, Magoha GA, Moses S: Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya. BJU Int 2005;96:1109–1113.
  21. Brown JE, Micheni KD, Grant EM, Mwenda JM, Muthiri FM, Grant AR: Varieties of male circumcision: a study from Kenya. Sex Transm Dis 2001;28:608–612.
  22. Kaplan GW: Complications of circumcision. Urol Clin North Am 1983;10:543–549.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50